The Scientist

» iPSCs and disease/medicine

Most Recent

image: Review: The End of Sex

Review: The End of Sex

By | May 13, 2016

Legal expert Henry Greely envisions a world in which advances in biotechnology obviate the need for sexual reproduction as we know it.

2 Comments

image: Sea Star Comeback?

Sea Star Comeback?

By | May 9, 2016

Hordes of baby sea stars on the Pacific coast survived the summer and winter of 2015—promising news about populations that have been devastated by a wasting disease.

0 Comments

image: Breast Milk Primes Gut for Microbes

Breast Milk Primes Gut for Microbes

By | May 5, 2016

Maternal antibodies engender a receptive gut environment for beneficial bacteria in newborn mice.

2 Comments

image: Transparency Now

Transparency Now

By | May 1, 2016

Science is messy. So lay it out, warts and all.

1 Comment

image: Contributors

Contributors

By and | May 1, 2016

Meet some of the people featured in the May 2016 issue of The Scientist.

0 Comments

image: Skin Cells Turned Into Immature Sperm

Skin Cells Turned Into Immature Sperm

By | April 29, 2016

The reprogrammed germ-like cells were unable to fertilize eggs, however. 

0 Comments

image: Antibodies Prevent HIV Infection in Monkeys

Antibodies Prevent HIV Infection in Monkeys

By | April 29, 2016

Infusing anti-HIV antibodies provides macaques with protection against infection for up to six months, according to a study.

0 Comments

image: “Hunger Hormone” No More?

“Hunger Hormone” No More?

By | April 20, 2016

Ghrelin promotes fat storage not feeding, according to a study.

3 Comments

image: Theranos in Criminal Probe

Theranos in Criminal Probe

By | April 19, 2016

Federal officials are investigating whether the diagnostics company misled investors.

2 Comments

image: Monitoring Mitochondrial Mutations

Monitoring Mitochondrial Mutations

By | April 18, 2016

Induced pluripotent stem cells—particularly those generated from older patients—should be screened for defects in mitochondrial DNA, a study shows.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. Does Productivity Diminish Research Quality?
  3. How Plants Evolved Different Ways to Make Caffeine
  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech